文献速递炎症性肠病

全外显子组测序分析揭示炎症性肠病背景下的基因-微生物群相互作用

Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD.
PubMed 文献 · Gut · 2020-07-10

该研究结合宿主全外显子组测序与粪便全基因组鸟枪法测序,分析525例炎症性肠病患者和939名人群对照的1464份粪便样本,采用四步分析鉴定出12个微生物数量性状位点,并发现影响免疫系统的常见和罕见遗传变异是塑造炎症性肠病背景下肠道微生物群的关键因素。

要点

  • 鉴定出12个微生物数量性状位点,包括IL17REL、MYRF、SEC16A和WDR78基因变异。
  • MYRF基因变异与乙酰辅酶A生物合成途径下降相关(错误发现率<0.05)。
  • 携带CYP2D6、GPR151和CD160罕见蛋白截断变异或拷贝数变异的参与者中观察到代谢潜力相关功能途径变化。

核心结论

  • 影响免疫系统的常见和罕见遗传变异均是塑造炎症性肠病背景下肠道微生物群的关键因素,并指向潜在的疾病治疗机制。

研究设计与样本

  • 结合宿主全外显子组测序与粪便全基因组鸟枪法测序,分析525例炎症性肠病患者和939名人群对照的1464份粪便样本。
  • 采用四步分析:全外显子组微生物数量性状位点分析、针对炎症性肠病相关基因组区域和蛋白截断变异的靶向分析、基于基因的负担检验以及两队列联合分析。

主要发现

  • 鉴定出12个微生物数量性状位点,包括炎症性肠病相关基因IL17REL、MYRF、SEC16A和WDR78中的变异。
  • 乙酰辅酶A生物合成途径的下降与MYRF基因变异相关(错误发现率<0.05)。
  • 携带CYP2D6、GPR151和CD160基因罕见蛋白截断变异或拷贝数变异的参与者中观察到代谢潜力相关功能途径的变化。
  • 交互分析证实了TNFSF15中先前已知的炎症性肠病疾病特异性微生物数量性状位点。

关键数值与推荐

  • 蛋白截断变异靶向分析纳入次要等位基因频率>5%的变异。
  • 基于基因的负担检验分析次要等位基因频率<5%的蛋白截断变异和位点频率<1%的外显子拷贝数变异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Both the gut microbiome and host genetics are known to play significant roles in the pathogenesis of IBD. However, the interaction between these two factors and its implications in the aetiology of IBD remain underexplored. Here, we report on the influence of host genetics on the gut microbiome in IBD. DESIGN: To evaluate the impact of host genetics on the gut microbiota of patients with IBD, we combined whole exome sequencing of the host genome and whole genome shotgun sequencing of 1464 faecal samples from 525 patients with IBD and 939 population-based controls. We followed a four-step analysis: (1) exome-wide microbial quantitative trait loci (mbQTL) analyses, (2) a targeted approach focusing on IBD-associated genomic regions and protein truncating variants (PTVs, minor allele frequency (MAF) >5%), (3) gene-based burden tests on PTVs with MAF <5% and exome copy number variations (CNVs) with site frequency <1%, (4) joint analysis of both cohorts to identify the interactions between disease and host genetics. RESULTS: We identified 12 mbQTLs, including variants in the IBD-associated genes IL17REL, MYRF, SEC16A and WDR78. For example, the decrease of the pathway acetyl-coenzyme A biosynthesis, which is involved in short chain fatty acids production, was associated with variants in the gene MYRF (false discovery rate <0.05). Changes in functional pathways involved in the metabolic potential were also observed in participants carrying rare PTVs or CNVs in CYP2D6, GPR151 and CD160 genes. These genes are known for their function in the immune system. Moreover, interaction analyses confirmed previously known IBD disease-specific mbQTLs in TNFSF15. CONCLUSION: This study highlights that both common and rare genetic variants affecting the immune system are key factors in shaping the gut microbiota in the context of IBD and pinpoints towards potential mechanisms for disease treatment.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Hu S, Vich Vila A, Gacesa R, et al. Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD. Gut. 2020. PMID: 32651235. doi:10.1136/gutjnl-2019-319706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。